ReviewSchizophrenia research. Cognition2026
Visual suppression deficits as a biomarker of working memory impairment in schizophrenia.
Review in Schizophrenia research. Cognition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Human biomarker navigator.iMeta · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Although working memory (WM) deficits are well established in schizophrenia (SZ), their underlying source is still unclear. It has been proposed that these WM deficits may depend on an imbalance between cortical excitation and inhibition (E/I), but its importance for SZ remains unclear. A potential biomarker for E/I is visual Surround Suppression (SS), where the apparent contrast of a central grating is typically suppressed by a surround with parallel orientation (versus orthogonal). Here we exploited the SS phenomenon to test whether E/I contributes to WM impairments in schizophrenia. Methods: Using centre-surround gratings, we measured psychophysical thresholds for contrast matching, detection and orientation discrimination, in 21 SZ patients and 20 matched controls. Using the same stimuli, we also measured WM accuracy and event-related potentials (ERPs) in a delayed-match-to-sample task. Results: In SZ participants, reduced SS predicted impaired WM performance as well as general cognitive measures (CANTAB). Similar relationships were also observed between other early visual measures (impaired contrast detection and orientation discrimination), WM and general cognition. In response to SS, there was reduced amplitude visual ERPs (P1, N1 and P2) in patients compared with controls. Furthermore, across both groups the P1 amplitude correlated with visual SS. Conclusion: Together, these findings provide evidence that imbalances in cortical excitation and inhibition may contribute to visual and some cognitive deficits in schizophrenia, and that SS may provide a behavioural and electrophysiological biomarker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.